Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

ApoE in Alzheimer’s disease: pathophysiology and therapeutic strategies
Ana‐Caroline Raulin, Sydney V. Doss, Zachary A. Trottier, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 306

Showing 1-25 of 306 citing articles:

Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases
Jian Sheng Loh, Wen Qi Mak, Li Tan, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 175
Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer’s disease
Erik C. B. Johnson, Shijia Bian, Rafi U. Haque, et al.
Nature Medicine (2023) Vol. 29, Iss. 8, pp. 1979-1988
Open Access | Times Cited: 84
Recent advances in Alzheimer’s disease: Mechanisms, clinical trials and new drug development strategies
Jifa Zhang, Yinglu Zhang, Jiaxing Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 80
Cell-autonomous effects of APOE4 in restricting microglial response in brain homeostasis and Alzheimer’s disease
Chia‐Chen Liu, Na Wang, Yuanxin Chen, et al.
Nature Immunology (2023) Vol. 24, Iss. 11, pp. 1854-1866
Closed Access | Times Cited: 59
Cell type-specific roles of APOE4 in Alzheimer disease
Jessica Blumenfeld, Oscar Yip, Min Joo Kim, et al.
Nature reviews. Neuroscience (2024) Vol. 25, Iss. 2, pp. 91-110
Open Access | Times Cited: 57
Alzheimer's Disease Puzzle: Delving into Pathogenesis Hypotheses
Mohammad Nasb, Weichu Tao, Ning Chen
Aging and Disease (2023)
Open Access | Times Cited: 53
Rationale for a Multi-Factorial Approach for the Reversal of Cognitive Decline in Alzheimer’s Disease and MCI: A Review
Rammohan V. Rao, Kaavya G. Subramaniam, Julie Gregory, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1659-1659
Open Access | Times Cited: 49
Iron homeostasis imbalance and ferroptosis in brain diseases
Haining Long, Wangshu Zhu, Liming Wei, et al.
MedComm (2023) Vol. 4, Iss. 4
Open Access | Times Cited: 39
Risk factors in developing amyloid related imaging abnormalities (ARIA) and clinical implications
Sarah J. Doran, Russell P. Sawyer
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 23
Multifaceted roles of APOE in Alzheimer disease
Rosemary J. Jackson, Bradley T. Hyman, Alberto Serrano‐Pozo
Nature Reviews Neurology (2024) Vol. 20, Iss. 8, pp. 457-474
Closed Access | Times Cited: 22
Mitochondria in Alzheimer’s Disease Pathogenesis
Allison B. Reiss, Shelly Gulkarov, Benna Jacob, et al.
Life (2024) Vol. 14, Iss. 2, pp. 196-196
Open Access | Times Cited: 21
Unveiling the future: Advancements in MRI imaging for neurodegenerative disorders
Lixin Du, Shubham Roy, Pan Wang, et al.
Ageing Research Reviews (2024) Vol. 95, pp. 102230-102230
Closed Access | Times Cited: 17
CRISPRi-based screens in iAssembloids to elucidate neuron-glia interactions
Emmy Li, Camila Benitez, Steven Boggess, et al.
Neuron (2025) Vol. 113, Iss. 5, pp. 701-718.e8
Open Access | Times Cited: 1
The impact of genetic variability on Alzheimer’s therapies: obstacles for pharmacogenetic progress
Ramón Cacabelos, Olaia Martínez-Iglesias, Natalia Cacabelos, et al.
Expert Opinion on Drug Metabolism & Toxicology (2025), pp. 1-28
Closed Access | Times Cited: 1
The impact of apolipoprotein E, type ∊4 allele on Alzheimer’s disease pathological biomarkers: a comprehensive post-mortem pilot-analysis
Ziyu Wan, Tao Ma
PLoS ONE (2025) Vol. 20, Iss. 2, pp. e0303486-e0303486
Open Access | Times Cited: 1
Lecanemab (Leqembi) is not the right drug for patients with Alzheimer’s disease
Markku Kurkinen
Advances in Clinical and Experimental Medicine (2023) Vol. 32, Iss. 9, pp. 943-947
Open Access | Times Cited: 35
Insight and Recommendations for Fragile X-Premutation-Associated Conditions from the Fifth International Conference on FMR1 Premutation
Flora Tassone, Dragana Protić, Emily G. Allen, et al.
Cells (2023) Vol. 12, Iss. 18, pp. 2330-2330
Open Access | Times Cited: 29
CRISPR/Cas9 genome editing for neurodegenerative diseases.
Jafar Nouri Nojadeh, Nur Seren Bildiren Eryilmaz, Berrin İmge Ergüder
PubMed (2023) Vol. 22, pp. 567-582
Closed Access | Times Cited: 24
TOMM40 Genetic Variants Cause Neuroinflammation in Alzheimer’s Disease
Yi‐Chun Chen, Shih‐Cheng Chang, Yun‐Shien Lee, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 4085-4085
Open Access | Times Cited: 22
Altered ubiquitin signaling induces Alzheimer’s disease-like hallmarks in a three-dimensional human neural cell culture model
Inbal Maniv, Mahasen Sarji, Anwar Bdarneh, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 22
Alzheimer’s Disease: Models and Molecular Mechanisms Informing Disease and Treatments
Kaden Nystuen, Shannon M. McNamee, Monica Akula, et al.
Bioengineering (2024) Vol. 11, Iss. 1, pp. 45-45
Open Access | Times Cited: 11
The Brain–Gut Axis, an Important Player in Alzheimer and Parkinson Disease: A Narrative Review
Eugenio Caradonna, Raffaello Nemni, Angelo Bifone, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 14, pp. 4130-4130
Open Access | Times Cited: 11
Updates in Alzheimer's disease: from basic research to diagnosis and therapies
Enjie Liu, Yao Zhang, Jian–Zhi Wang
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 11
Gut microbiota-host lipid crosstalk in Alzheimer’s disease: implications for disease progression and therapeutics
Yaxi Luo, Ling-Ling Yang, Xiu‐Qing Yao
Molecular Neurodegeneration (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 10
Epigenetic Changes in Alzheimer’s Disease: DNA Methylation and Histone Modification
Laura M. De Plano, Alessandra Saitta, Salvatore Oddo, et al.
Cells (2024) Vol. 13, Iss. 8, pp. 719-719
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top